Jonathan Kotula, PhD is driven to pursue biotechnology solutions for human health challenges. He is an expert in synthetic biology and host-microbial interactions, with over 15 years of research and development experience. He is the Head of Science at Felix Biotechnology, Inc. where he leads the R&D team to engineer phages to treat antibiotic resistant infections. He has led interdisciplinary teams of researchers to develop tools for bacterial genome editing for therapeutic purposes, has initiated research programs at Synlogic Inc. and Caribou Biosciences Inc., and is an inventor on several bacterial engineering patents. He holds a PhD from Duke University and has conducted postdoctoral research at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering.